Neumora Therapeutics, Inc. (NMRA) SEC filings
NMRA SEC filings moved a median of -0.60% by the close. NMRA SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the NMRA overview →
58 measured NMRA SEC filing events.
Where these NMRA SEC filings landedvs 58 measured NMRA SEC filing reactions
| Middle 50% of NMRA SEC filing reactions | -5.33% to +2.38% |
|---|---|
| Median reaction (to close) | -0.60% |
| Measured reactions | 58 |
Point-in-time · zero look-ahead
Half of the 58 NMRA SEC filing events with a measured close landed between -5.33% and +2.38%; 47% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Neumora Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -3.43% | -5.33% | |
| Form 8-K Neumora Therapeutics, For: Aug 14 | SEC filing · Form 8-K | -3.43% | -5.33% | |
| Form 8-K Neumora Therapeutics, For: Jul 27 | SEC filing · Form 8-K | +1.32% | +9.93% | |
| Form 8-K Neumora Therapeutics, For: Jun 10 | SEC filing · Form 8-K | +2.32% | -1.69% | |
| Form 8-K Neumora Therapeutics, For: May 27 | SEC filing · Form 8-K | -1.35% | -1.62% | |
| Form 10-Q Neumora Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.52% | -7.11% | |
| Form 8-K Neumora Therapeutics, For: May 07 | SEC filing · Form 8-K | -0.43% | -16.74% | |
| Form DEF 14A Neumora Therapeutics, For: May 27 | SEC filing · Form DEF | -0.47% | +3.30% | |
| Form DEFA14A Neumora Therapeutics, | SEC filing · Form DEFA14A | -0.47% | +3.30% | |
| Form 10-K Neumora Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -6.52% | -10.23% | |
| Form 8-K Neumora Therapeutics, For: Mar 30 | SEC filing · Form 8-K | -6.52% | -10.23% | |
| Form S-8 Neumora Therapeutics, | SEC filing · Form S-8 | -6.52% | -10.23% | |
| Form 8-K Neumora Therapeutics, For: Feb 11 | SEC filing · Form 8-K | -1.13% | +2.39% | |
| Form 8-K Neumora Therapeutics, For: Jan 12 | SEC filing · Form 8-K | -5.08% | -2.20% | |
| Form 8-K Neumora Therapeutics, For: Jan 05 | SEC filing · Form 8-K | -3.53% | -11.14% | |
| Form 8-K Neumora Therapeutics, For: Nov 17 | SEC filing · Form 8-K | -2.15% | -7.30% | |
| Form 10-Q Neumora Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -1.63% | +2.40% | |
| Form 8-K Neumora Therapeutics, For: Nov 06 | SEC filing · Form 8-K | +0.00% | +7.50% | |
| Form 8-K Neumora Therapeutics, For: Oct 27 | SEC filing · Form 8-K | -3.67% | -0.37% | |
| Form 10-Q Neumora Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +1.81% | -0.60% | |
| Form 8-K Neumora Therapeutics, For: Aug 06 | SEC filing · Form 8-K | +1.81% | -0.60% | |
| Form 8-K Neumora Therapeutics, For: May 28 | SEC filing · Form 8-K | +2.10% | +8.39% | |
| Form 8-K Neumora Therapeutics, For: May 14 | SEC filing · Form 8-K | +0.07% | +3.06% | |
| Form DEFA14A Neumora Therapeutics, | SEC filing · Form DEFA14A | +0.07% | +3.06% | |
| Form 10-Q Neumora Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +5.32% | -1.71% | |
| Form 8-K Neumora Therapeutics, For: May 12 | SEC filing · Form 8-K | +5.32% | -1.71% | |
| Form DEF 14A Neumora Therapeutics, For: May 28 | SEC filing · Form DEF | -0.59% | +2.20% | |
| Form DEFA14A Neumora Therapeutics, | SEC filing · Form DEFA14A | -0.59% | +2.20% | |
| Form 8-K/A Neumora Therapeutics, For: Feb 13 | SEC filing · Form 8-K | +0.04% | -2.93% | |
| Form PRE 14A Neumora Therapeutics, For: May 28 | SEC filing · Form PRE | +0.04% | -2.93% | |
| Form EFFECT Neumora Therapeutics, | SEC filing · Form EFFECT | -0.92% | +0.92% | |
| Form 10-K Neumora Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.63% | -12.19% | |
| Form 8-K Neumora Therapeutics, For: Mar 03 | SEC filing · Form 8-K | -0.63% | -12.19% | |
| Form POS AM Neumora Therapeutics, | SEC filing · Form POS | +8.03% | +2.92% | |
| Form POSASR Neumora Therapeutics, | SEC filing · Form POSASR | -0.63% | -12.19% | |
| Form S-8 Neumora Therapeutics, | SEC filing · Form S-8 | +8.03% | +2.92% | |
| Form 8-K/A Neumora Therapeutics, For: Feb 13 | SEC filing · Form 8-K | -0.84% | -3.93% | |
| Form 8-K Neumora Therapeutics, For: Feb 13 | SEC filing · Form 8-K | +0.58% | +1.16% | |
| Form 8-K Neumora Therapeutics, For: Jan 13 | SEC filing · Form 8-K | -1.82% | +10.50% | |
| Form 8-K Neumora Therapeutics, For: Jan 02 | SEC filing · Form 8-K | +8.99% | +4.23% | |
| Form 10-Q Neumora Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.61% | -6.14% | |
| Form 8-K Neumora Therapeutics, For: Nov 12 | SEC filing · Form 8-K | -2.19% | -13.13% | |
| Form S-3ASR Neumora Therapeutics, | SEC filing · Form S-3ASR | +0.27% | +6.48% | |
| Form 10-Q Neumora Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +1.25% | -1.34% | |
| Form 8-K Neumora Therapeutics, For: Aug 06 | SEC filing · Form 8-K | +0.34% | +0.76% | |
| Form 8-K Neumora Therapeutics, For: Jun 13 | SEC filing · Form 8-K | +0.41% | -3.30% | |
| Form 10-Q Neumora Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.21% | -1.88% | |
| Form 8-K Neumora Therapeutics, For: May 07 | SEC filing · Form 8-K | +1.93% | +4.92% | |
| Form DEF 14A Neumora Therapeutics, For: Jun 13 | SEC filing · Form DEF | -0.28% | +2.35% | |
| Form DEFA14A Neumora Therapeutics, | SEC filing · Form DEFA14A | -0.28% | +2.35% | |
| Form 8-K Neumora Therapeutics, For: Apr 15 | SEC filing · Form 8-K | +1.80% | +0.99% | |
| Form 10-K Neumora Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.20% | -8.30% | |
| Form 8-K Neumora Therapeutics, For: Mar 07 | SEC filing · Form 8-K | +2.49% | +0.74% | |
| Form S-8 Neumora Therapeutics, | SEC filing · Form S-8 | +0.20% | -8.30% | |
| Form 8-K Neumora Therapeutics, For: Jan 08 | SEC filing · Form 8-K | -1.33% | -1.14% | |
| Form 8-K Neumora Therapeutics, For: Nov 27 | SEC filing · Form 8-K | +0.00% | +0.92% | |
| Form 10-Q Neumora Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +1.58% | |
| Form 8-K Neumora Therapeutics, For: Nov 01 | SEC filing · Form 8-K | +0.00% | +1.58% |
Keep exploring
More NMRA: earnings → · analyst actions → · NMRA overview →